{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:46:09Z","timestamp":1794048369666,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","award":["SCR_019170"],"award-info":[{"award-number":["SCR_019170"]}],"id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["U19 AI144181"],"award-info":[{"award-number":["U19 AI144181"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["U01 AI182180"],"award-info":[{"award-number":["U01 AI182180"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SCR_019170"],"award-info":[{"award-number":["SCR_019170"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vaccine.2024.126526","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T23:43:49Z","timestamp":1731455029000},"page":"126526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P1","title":["Intranasal immunization with CPAF combined with ADU-S100 induces an effector CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum"],"prefix":"10.1016","volume":"43","author":[{"given":"Taylor B.","family":"Poston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zwarycz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Grace","family":"Polson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacy S.","family":"Yount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtne","family":"Hanlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Jaras Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Mae","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rozzelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Fairman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Esser-Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Darville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2024.126526_bb0010","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1086\/513844","article-title":"Chlamydia trachomatis infections: progress and problems","volume":"179","author":"Stamm","year":"1999","journal-title":"JInfectDis"},{"key":"10.1016\/j.vaccine.2024.126526_bb0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases: the case for screening","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2024.126526_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MOP.0000000000000578","article-title":"The growing epidemic of sexually transmitted infections in adolescents: a neglected population","volume":"30","author":"Shannon","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2024.126526_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiv438","article-title":"Analysis of factors driving incident and ascending infection and the role of serum antibody in Chlamydia trachomatis genital tract infection","volume":"213","author":"Russell","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126526_bb0030","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/infdis\/jiw485","article-title":"Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection","volume":"214","author":"Russell","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126526_bb0035","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/infdis\/jiab496","article-title":"Reduced endometrial Ascension and enhanced reinfection associated with immunoglobulin G antibodies to specific Chlamydia trachomatis proteins in women at risk for Chlamydia","volume":"225","author":"Liu","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126526_bb0040","doi-asserted-by":"crossref","first-page":"jiae443","DOI":"10.1093\/infdis\/jiae443","article-title":"Chlamydia trachomatis induces low-frequency, sustained CD4 T cell responses in most women, predominantly targeting chlamydial protease-like activity factor","volume":"9","author":"Li","year":"2024","journal-title":"CPAF J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126526_bb0045","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4049\/jimmunol.158.7.3344","article-title":"Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways","volume":"158","author":"Perry","year":"1997","journal-title":"JImmunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0050","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B","article-title":"IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection","volume":"29","author":"Wang","year":"1999","journal-title":"EurJ Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa8205","article-title":"A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.126526_bb0060","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.1700914","article-title":"A Chlamydia-specific TCR-transgenic mouse demonstrates Th1 Polyfunctionality with enhanced effector function","volume":"199","author":"Poston","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0070","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2007.02.010","article-title":"Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection","volume":"25","author":"Cong","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126526_bb0075","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126526_bb0080","first-page":"8","article-title":"The age of cyclic dinucleotide vaccine adjuvants","author":"Gogoi","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126526_bb0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an Intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2024.126526_bb0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor Spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Phase Ib Study Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2024.126526_bb0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2020.09.040","article-title":"Dual-adjuvant effect of pH-sensitive liposomes loaded with STING and TLR9 agonists regress tumor development by enhancing Th1 immune response","volume":"328","author":"Kocabas","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.126526_bb0100","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/eji.201445132","article-title":"TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN","volume":"45","author":"Temizoz","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005300","article-title":"Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi","volume":"11","author":"Matos","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.126526_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110150","article-title":"Cyclic GMP-AMP displays mucosal adjuvant activity in mice","volume":"9","author":"Skrnjug","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.126526_bb0115","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","article-title":"Co VLPST: efficacy and safety of a recombinant plant-based Adjuvanted Covid-19 vaccine","volume":"386","author":"Hager","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.126526_bb0120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41591-021-01370-1","article-title":"Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19","volume":"27","author":"Ward","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.126526_bb0125","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(21)00241-5","article-title":"Safety and immunogenicity of S-trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial","volume":"397","author":"Richmond","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126526_bb0130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1021\/acsmedchemlett.1c00267","article-title":"Improving the Adjuvanticity of small molecule immune Potentiators using covalently linked NF-kappaB modulators","volume":"12","author":"Kimani","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.vaccine.2024.126526_bb0135","doi-asserted-by":"crossref","unstructured":"Poston T.B., Girardi J., Polson A.G., Bhardwaj A., Yount K.S., Jaras Salas I., et al. Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naive mice. Mucosal Immunol 2024;Oct;17(5):1005-1018.","DOI":"10.1016\/j.mucimm.2024.06.012"},{"key":"10.1016\/j.vaccine.2024.126526_bb0140","first-page":"86","article-title":"Darville T: T cell-independent gamma interferon and B cells cooperate to prevent mortality associated with disseminated Chlamydia muridarum genital tract infection","author":"Poston","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126526_bb0145","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/IAI.01118-10","article-title":"Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. Trachomatis but not by C. Muridarum","volume":"79","author":"O\u2019Connell","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126526_bb0150","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1128\/iai.64.12.4976-4983.1996","article-title":"Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection","volume":"64","author":"Kelly","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126526_bb0155","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/iai.65.8.3065-3073.1997","article-title":"Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response","volume":"65","author":"Darville","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126526_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.200804023","article-title":"Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease","volume":"182","author":"Paschen","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0165","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1021\/acs.biochem.9b00522","article-title":"Insights into the autoproteolytic processing and catalytic mechanism of the Chlamydia trachomatis virulence-associated protease CPAF","volume":"58","author":"Dudiak","year":"2019","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.vaccine.2024.126526_bb0170","first-page":"125909","article-title":"An intranasal nanoparticle vaccine elicits protective immunity against","volume":"42","author":"Sefat","year":"2024","journal-title":"Mycobacterium tuberculosis. Vaccine"},{"key":"10.1016\/j.vaccine.2024.126526_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.647220","article-title":"Subunit vaccine ESAT-6:c-di-AMP delivered by intranasal route elicits immune responses and protects against Mycobacterium tuberculosis infection","volume":"11","author":"Ning","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0180","article-title":"Intranasal immunization with a c-di-GMP-Adjuvanted acellular pertussis vaccine provides superior immunity against Bordetella pertussis in a mouse model","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0185","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41385-018-0080-x","article-title":"Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T(RM) cells","volume":"11","author":"Allen","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1574-695X.2008.00517.x","article-title":"A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge","volume":"55","author":"Murthy","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0200","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.164.12.6113","article-title":"Immune complex and fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses","volume":"164","author":"Hamano","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0205","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.7150\/ijbs.81210","article-title":"TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses","volume":"19","author":"Yang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.vaccine.2024.126526_bb0210","article-title":"Intradermal immunization of SARS-CoV-2 original strain trimeric spike protein associated to CpG and AddaS03 adjuvants, but Not MPL, provide strong humoral and cellular response in mice","volume":"10","author":"Firmino-Cruz","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126526_bb0215","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cellimm.2006.10.002","article-title":"The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells","volume":"242","author":"Murphey","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0225","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41467-024-45526-2","article-title":"Immune signature of Chlamydia vaccine CTH522\/CAF(R)01 translates from mouse-to-human and induces durable protection in mice","volume":"15","author":"Olsen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126526_bb0230","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/IAI.01374-09","volume":"78","author":"Yu","year":"2010","journal-title":"Infect Immun"},{"issue":"1176\u201388","key":"10.1016\/j.vaccine.2024.126526_bb0235","article-title":"Effector T(H)17 cells give rise to Long-lived T(RM) cells that are essential for an immediate response against bacterial infection","volume":"178","author":"Amezcua Vesely","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.126526_bb0240","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/mi.2014.136","article-title":"Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge","volume":"8","author":"Monin","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2024.126526_bb0245","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.mucimm.2024.06.012","article-title":"Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naive mice","volume":"17","author":"Poston","year":"2024","journal-title":"Mucosal Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:43:32Z","timestamp":1734018212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"alternative-id":["S0264410X24012088"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126526","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunization with CPAF combined with ADU-S100 induces an effector CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126526"}}